VEGFA and renal cell carcinoma: Improved understanding of the molecular mechanisms associated with the disease, including increased transcription of vascular endothelial growth factor (VEGF), platelet-derived growth factor, and epidermal growth factor, has led to the development of multiple agents targeting RCC-promoting pathways.